Inhibrx, Inc. is a biotechnology company that develops novel biologic therapeutic candidates for various diseases such as cancer. They are currently working on several candidates, including INBRX-109, INBRX-105, INBRX-101 and INBRX-106, all in different stages of clinical trials. The company was founded in 2010 and based in La Jolla, California.